uniQure NV (QURE)
4.69
-0.20
(-4.09%)
USD |
NASDAQ |
Jun 17, 16:00
4.705
+0.02
(+0.32%)
Pre-Market: 20:00
uniQure Cash and Short Term Investments (Quarterly): 555.68M for March 31, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 555.68M |
| December 31, 2023 | 617.89M |
| September 30, 2023 | 658.91M |
| June 30, 2023 | 628.59M |
| March 31, 2023 | 315.34M |
| December 31, 2022 | 352.84M |
| September 30, 2022 | 440.31M |
| June 30, 2022 | 500.52M |
| March 31, 2022 | 524.89M |
| December 31, 2021 | 556.26M |
| September 30, 2021 | 578.46M |
| June 30, 2021 | 677.33M |
| March 31, 2021 | 260.81M |
| December 31, 2020 | 244.93M |
| September 30, 2020 | 279.49M |
| June 30, 2020 | 314.26M |
| March 31, 2020 | 342.03M |
| December 31, 2019 | 377.79M |
| September 30, 2019 | 403.16M |
| June 30, 2019 | 184.10M |
| March 31, 2019 | 208.79M |
| December 31, 2018 | 234.90M |
| Date | Value |
|---|---|
| September 30, 2018 | 239.55M |
| June 30, 2018 | 259.18M |
| March 31, 2018 | 140.82M |
| December 31, 2017 | 159.37M |
| September 30, 2017 | 88.93M |
| June 30, 2017 | 104.09M |
| March 31, 2017 | 120.27M |
| December 31, 2016 | 132.50M |
| September 30, 2016 | 157.43M |
| June 30, 2016 | 184.25M |
| March 31, 2016 | 209.26M |
| December 31, 2015 | 221.63M |
| September 30, 2015 | 241.35M |
| June 30, 2015 | 203.97M |
| March 31, 2015 | 46.78M |
| December 31, 2014 | 64.72M |
| September 30, 2014 | 79.66M |
| June 30, 2014 | 98.31M |
| March 31, 2014 | 106.63M |
| December 31, 2013 | 32.88M |
| September 30, 2013 | 42.41M |
| December 31, 2012 | 0.3478M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
184.10M
Minimum
Jun 2019
677.33M
Maximum
Jun 2021
440.68M
Average
421.74M
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| ProQR Therapeutics NV | 110.92M |
| Merus NV | 337.50M |
| argenx SE | -- |
| Pharming Group | 201.97M |
| Pharvaris NV | 397.77M |